Liezl Gambe

LTR Pharma (ASX:LTP) announced that its Phase 1 clinical study of SPONTAN nasal spray has been accepted for podium presentation at the World Meeting on Sexual Medicine 2026.

BlueScope Steel (ASX:BSL) has rebuffed a $13.2 billion takeover proposal from Stokes family–controlled SGH and its US partner, Steel Dynamics (NASDAQ:STLD).

CoStar Group (NASDAQ:CSGP), a leading provider of online real estate marketplaces, information, analytics, and 3D digital twin technology in the property markets, today announced an update on its key business, financial, and corporate governance initiatives for 2026 and beyond.

Genprex (NASDAQ:GNPX) issued a clinical update on January 7, 2026, for its diabetes gene therapy program, highlighting significant preclinical progress and regulatory advancements for GPX-002.

Merck & Co. (NYSE:MRK) began a late-stage clinical trial for a new combination therapy aimed at untreated lung cancer, seeking to eliminate the need for traditional chemotherapy and intravenous infusions for patients with a specific genetic mutation.

Cal-Maine Foods (NASDAQ:CALM) reported a sharp decline in second-quarter earnings on Wednesday, January 7, 2026, as the primary U.S. egg producer grapples with a retreat from the record-high commodity prices that fueled prior windfalls.

María Corina Machado says she is ready to lead Venezuela following the ousting of President Nicolás Maduro.

A gang rape survivor in India has returned home after hospital treatment, with police continuing legal proceedings against two suspects.

US lawmakers are preparing to debate the CLARITY Act as the crypto industry awaits long-sought regulatory clarity.

The US Senate has confirmed investigative journalist Sara Carter as Drug Czar, marking a historic first for the role.